{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:24:16Z","timestamp":1768436656965,"version":"3.49.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"the Portuguese League Against Cancer\u2014Regional Nucleus of the North (Liga Portuguesa Contra o Cancro\u2014N\u00facleo Regional do Norte), by the Research Center of the Portuguese Oncology Institute of Porto","award":["PI86-CI-IPOP-66-2017"],"award-info":[{"award-number":["PI86-CI-IPOP-66-2017"]}]},{"name":"FCT\/MCTES (PIDDAC) and 2SMART","award":["NORTE-01-0145-FEDER-000054"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000054"]}]},{"name":"Norte Portugal Regional Operational Programme","award":["NORTE 2020"],"award-info":[{"award-number":["NORTE 2020"]}]},{"name":"the European Regional Development Fund (ERDF). Joana M.O. Santos","award":["SFRH\/BD\/135871\/2018"],"award-info":[{"award-number":["SFRH\/BD\/135871\/2018"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Biomarkers"],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.1080\/1354750x.2023.2269320","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T10:05:32Z","timestamp":1699524332000},"page":"617-627","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6268-524X","authenticated-orcid":false,"given":"Joana M. O.","family":"Santos","sequence":"first","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal"},{"name":"Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3680-7757","authenticated-orcid":false,"given":"Val\u00e9ria","family":"Tavares","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal"},{"name":"Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal"},{"name":"Abel Salazar Institute of Biomedical Sciences (ICBAS) of the University of Porto, Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2151-2449","authenticated-orcid":false,"given":"Rui M.","family":"Gil da Costa","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal"},{"name":"Postgraduate Programme in Adult Health (PPGSAD), Department of Morphology, Federal, University of Maranh\u00e3o (UFMA), and UFMA University Hospital (HUUFMA), S\u00e3o Lu\u00eds, Brazil"},{"name":"Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Tr\u00e1s-os-Montes e Alto Douro (UTAD), Vila Real, Portugal"},{"name":"LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, PortugalPorto"},{"name":"ALiCE - Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8373","authenticated-orcid":false,"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)\/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal"},{"name":"Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal"},{"name":"Abel Salazar Institute of Biomedical Sciences (ICBAS) of the University of Porto, Porto, Portugal"},{"name":"Virology Service, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal"},{"name":"Biomedical Research Center (CEBIMED), Faculty of Health Sciences of the Fernando Pessoa University, Porto, Portugal"}]}],"member":"301","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2549-5"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.7.4358-4368.1994"},{"key":"e_1_3_5_4_1","first-page":"114","article-title":"How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market","volume":"30","author":"Bonneau E","year":"2019","unstructured":"Bonneau E, Neveu B, Kostantin E, et\u00a0al. 2019. How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. Ejifcc. 30:114\u2013127.","journal-title":"Ejifcc"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.07.015"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21386"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00693-4"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060317"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101656"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.356"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092216"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000343320"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.03.033"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154386"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1664560"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2019.01.001"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.06.006"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-01881-0"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-013-1801-9"},{"key":"e_1_3_5_21_1","first-page":"523","article-title":"MicroRNA expressions in HPV-induced cervical dysplasia and cancer","volume":"35","author":"Gocze K","year":"2015","unstructured":"Gocze K, Gombos K, Kovacs K, et\u00a0al. 2015. MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res. 35:523\u2013530.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31099"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.08.003"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2017.01.005"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2479-7"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-015-0052-6"},{"key":"e_1_3_5_27_1","first-page":"2897","article-title":"miR146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NFkappaB signaling by targeting TRAF6","volume":"41","author":"Li T","year":"2019","unstructured":"Li T, Li M, Xu C, et\u00a0al. 2019. miR146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NFkappaB signaling by targeting TRAF6. Oncol Rep. 41:2897\u20132908.","journal-title":"Oncol Rep"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S193097"},{"key":"e_1_3_5_29_1","first-page":"3981","article-title":"MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma","volume":"25","author":"Liu DK","year":"2021","unstructured":"Liu DK, Yu S, Li JP, et\u00a0al. 2021. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 25:3981\u20133989.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0685-9"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.5475"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.5387"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-855502"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116868"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.02.020"},{"key":"e_1_3_5_36_1","first-page":"957","article-title":"Interplay between mast cells and lymphatic vessels in different molecular types of breast cancer","volume":"33","author":"Raica M","year":"2013","unstructured":"Raica M, Cimpean AM, Ceausu R, et\u00a0al. 2013. Interplay between mast cells and lymphatic vessels in different molecular types of breast cancer. Anticancer Res. 33:957\u2013963.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/304584"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2018.01.017"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.03.008"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-021-00866-1"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5085-z"},{"issue":"7","key":"e_1_3_5_42_1","first-page":"1294","article-title":"Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice","volume":"57","author":"Smith-McCune K","year":"1997","unstructured":"Smith-McCune K, Zhu YH, Hanahan D, Arbeit J. 1997. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57(7):1294\u20131300.","journal-title":"Cancer Res"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1712018114"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.09.018"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.007385-0"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11452"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6477"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.232.85"},{"key":"e_1_3_5_50_1","first-page":"9869","article-title":"LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155","volume":"24","author":"Yang TJ","year":"2020","unstructured":"Yang TJ, Wang L, Zhang Y, et\u00a0al. 2020. LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155. Eur Rev Med Pharmacol Sci. 24:9869\u20139879.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.09.143"}],"container-title":["Biomarkers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1354750X.2023.2269320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:21:48Z","timestamp":1727220108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1354750X.2023.2269320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10,3]]}},"alternative-id":["10.1080\/1354750X.2023.2269320"],"URL":"https:\/\/doi.org\/10.1080\/1354750x.2023.2269320","relation":{},"ISSN":["1354-750X","1366-5804"],"issn-type":[{"value":"1354-750X","type":"print"},{"value":"1366-5804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmk20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmk20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}